April 2012

Lundbeck, Inc's Onfi

April 26, 2012

New Drug Review

The FDA approved Lundbeck, Inc's Onfi (clobazam) as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome in patients that are 2 years and older.

Impact of CMS' Proposed Sunshine Reporting Rule

April 09, 2012

Washington Insights

Compliance with the much-anticipated implementation of the "Sunshine Act" will impact specialty pharmacies nationwide. Our experts take a closer look at the potential changes and how they will affect the industry now and in the future.

Putting "High-Tech, High-Touch" Back into Specialty Pharmacy

April 09, 2012

Viewpoints: The Last Word

The roots of specialty pharmacy began in community retail pharmacy. Given a choice, specialty patients will choose a local specialty pharmacy to access their medicines and manage their care.

Considerations for LTC Pharmacy Short-Fill Dispensing

April 09, 2012


The new Final Rule to dispense all brand name drugs to Medicare Part D enrollees in long-term care facilities by the Centers for Medicare & Medicaid Services will impact pharmacists and patients.

The Drumbeat of Medication Adherence

April 09, 2012

From the Chairman

The issue of adherence is critical and it impacts cost and delivery of care. As the population ages, medication adherence becomes even more of a focal point for health care professionals.